We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-14.27%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$123B
AUM Growth
-$24.7B
(-17%)
Cap. Flow
-$418M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
30.06%
Holding
304
New
10
Increased
88
Reduced
149
Closed
13
Avg Time Held
3.8
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$485M |
| 2 |
Hess
HES
|
+$460M |
| 3 |
Wells Fargo
WFC
|
+$356M |
| 4 |
Albemarle
ALB
|
+$291M |
| 5 |
Linde
LIN
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$468M |
| 2 |
Dell
DELL
|
+$283M |
| 3 |
Adobe
ADBE
|
+$261M |
| 4 |
Praxair Inc
PX
|
+$231M |
| 5 |
NetApp
NTAP
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 25.96% |
| 3 | Industrials | 15.66% |
| 4 | Financials | 9.32% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Textron
TXT
$12.9B
| $238M | 0.19% |
5,175,614
+190,354
| +4% | +$10.7M |
2016 Q2
10 quarters
|
|
102
Transocean
RIG
$6.15B
| $235M | 0.19% |
33,824,639
+1,655,800
| +5% | +$16.9M |
2013 Q2
22 quarters
|
|
103
US Bancorp
USB
$89.4B
| $234M | 0.19% |
5,125,479
-14,900
| -0.3% | -$767K |
2013 Q4
20 quarters
|
|
104
Norwegian Cruise Line
NCLH
$7.07B
| $234M | 0.19% |
5,510,450
+184,125
| +3% | +$8.92M |
2014 Q1
19 quarters
|
|
|
105
Linde
LIN
$227B
| $223M | 0.18% |
+1,431,369
| New | +$226M |
2018 Q4
0 quarters
|
|
106
DELISTED
Sprint Corporation
S
| $203M | 0.16% |
34,865,300
-1,719,200
| -5% | -$10.6M |
2014 Q3
17 quarters
|
|
107
DELISTED
Exact Sciences
EXAS
| $202M | 0.16% |
3,195,102
-383,998
| -11% | -$26.4M |
2014 Q2
18 quarters
|
|
108
Zimmer Biomet
ZBH
$18B
| $198M | 0.16% |
1,961,481
+196,133
| +11% | +$22.1M |
2013 Q2
22 quarters
|
|
|
SFLY
109
DELISTED
Shutterfly, Inc.
SFLY
| $196M | 0.16% |
4,876,282
-56,200
| -1% | -$2.95M |
2013 Q2
22 quarters
|
|
110
EOG Resources
EOG
$80.1B
| $190M | 0.15% |
2,173,096
+17,459
| +0.8% | +$1.87M |
2013 Q2
22 quarters
|
|
111
DXC Technology
DXC
$2.2B
| $186M | 0.15% |
3,491,535
-305,952
| -8% | -$21.1M |
2017 Q2
6 quarters
|
|
|
VMW
112
DELISTED
VMware, Inc
VMW
| $180M | 0.15% |
1,313,895
-312,700
| -19% | -$47.2M |
2013 Q2
22 quarters
|
|
|
ELLI
113
DELISTED
Ellie Mae Inc
ELLI
| $176M | 0.14% |
2,800,445
-90,900
| -3% | -$6.47M |
2013 Q2
22 quarters
|
|
114
MarketAxess Holdings
MKTX
$5.79B
| $165M | 0.13% |
780,220
-54,200
| -6% | -$11.2M |
2013 Q2
22 quarters
|
|
115
Applied Materials
AMAT
$341B
| $163M | 0.13% |
4,993,610
+706,600
| +16% | +$24.2M |
2013 Q2
22 quarters
|
|
116
Elanco Animal Health
ELAN
$11.8B
| $156M | 0.13% |
4,962,199
+1,212,199
| +32% | +$39.7M |
2018 Q3
1 quarter
|
|
|
POLY
117
DELISTED
Plantronics, Inc.
POLY
| $148M | 0.12% |
4,485,550
| – | – |
2013 Q2
22 quarters
|
|
118
Stratasys
SSYS
$624M
| $138M | 0.11% |
7,646,489
+35,689
| +0.5% | +$746K |
2013 Q2
22 quarters
|
|
119
Curtiss-Wright
CW
$18.5B
| $137M | 0.11% |
1,343,700
+40,700
| +3% | +$4.55M |
2013 Q3
21 quarters
|
|
120
Entegris
ENTG
$22.4B
| $134M | 0.11% |
4,789,641
-20,288
| -0.4% | -$549K |
2013 Q2
22 quarters
|
|
121
Apple
AAPL
$4.99T
| $129M | 0.1% |
3,280,400
-140,000
| -4% | -$6.79M |
2013 Q2
22 quarters
|
|
122
BeOne Medicines Ltd
ONC
$42.3B
| $129M | 0.1% |
921,539
+46,000
| +5% | +$6.1M |
2017 Q2
6 quarters
|
|
123
Comscore
SCOR
$61.2M
| $125M | 0.1% |
432,277
+13,115
| +3% | +$4.23M |
2013 Q2
22 quarters
|
|
|
NUAN
124
DELISTED
Nuance Communications, Inc.
NUAN
| $121M | 0.1% |
10,606,363
+243,162
| +2% | +$3.41M |
2013 Q2
22 quarters
|
|
125
Raymond James Financial
RJF
$30.3B
| $119M | 0.1% |
+2,391,975
| New | +$127M |
2018 Q4
0 quarters
|
|
Similar funds
Primecap Management's Q4 2018 Portfolio in Review
As of Q4 2018, Primecap Management held 304 positions worth $123B, down 17% from $148B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2018 filing shows 10 new, 88 increased, 149 reduced and 13 closed positions. Its largest new stake was Linde: 1,431,369 shares worth $223M. The largest sale was Eli Lilly, an estimated $468M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2018 buy was Linde: 1,431,369 shares worth $223M.
- Primecap Management added most to Bank of America in Q4 2018, an estimated $485M increase.
- Primecap Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $468M.
- Primecap Management fully exited Praxair Inc in Q4 2018, selling an estimated $231M.
- Primecap Management's ten largest holdings make up 30% of its $123B portfolio in Q4 2018.
- Primecap Management opened 10 new positions and closed 13 in Q4 2018.
- Primecap Management's portfolio value fell 17% quarter-over-quarter to $123B.
Based on Primecap Management's 13F filing for Q4 2018, filed 12 Feb 2019.